Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Breast Neoplasms and SRD5A2[original query] |
|---|
| The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001 Dec 10 (12): 1287-93. Spurdle A B, Hopper J L, Chen X, Dite G S, McCredie M R, Giles G G, Venter D J, Southey M C, Purdie D M, Chenevix-Trench |
| A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women. Breast cancer research : BCR 2002 4 (4): R8. Yang Chunxia, Hamajima Nobuyuki, Iwata Hiroji, Saito Toshiko, Matsuo Keitaro, Hirose Kaoru, Inoue Manami, Takezaki Toshiro, Tajima Kaz |
| The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003 Nov 12 (11 Pt 1): 1194-9. van Gils Carla H, Onland-Moret N Charlotte, Roest Mark, van Noord Paulus A H, Peeters Petra H |
| A common polymorphism within the steroid 5-alpha-reductase type 2 gene and timing of menopause in Caucasian women. European journal of obstetrics, gynecology, and reproductive biology 2006 Apr 125 (2): 221-5. Huber Ambros, Grimm Christoph, Huber Johannes C, Schneeberger Christian, Leodolter Sepp, Reinthaller Alexander, Tempfer Clemens B, Hefler Lukas |
| Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma. Rejuvenation research 2006 9 (1): 56-60. Corder Elizabeth H, Hefler Lukas |
| Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 2007 Jun . Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H |
| Consortium analysis of 7 candidate SNPs for ovarian cancer. International journal of cancer. Journal international du cancer 2008 Jul 123 (2): 380-8. Ramus Susan J, Vierkant Robert A, Johnatty Sharon E, Pike Malcolm C, Van Den Berg David J, Wu Anna H, Pearce Celeste Leigh, Menon Usha, Gentry-Maharaj Aleksandra, Gayther Simon A, Dicioccio Richard A, McGuire Valerie, Whittemore Alice S, Song Honglin, Easton Douglas F, Pharoah Paul D P, Garcia-Closas Montserrat, Chanock Stephen, Lissowska Jolanta, Brinton Louise, Terry Kathryn L, Cramer Daniel W, Tworoger Shelley S, Hankinson Susan E, Berchuck Andrew, Moorman Patricia G, Schildkraut Joellen M, Cunningham Julie M, Liebow Mark, Kjaer Susanne Krüger, Hogdall Estrid, Hogdall Claus, Blaakaer Jan, Ness Roberta B, Moysich Kirsten B, Edwards Robert P, Carney Michael E, Lurie Galina, Goodman Marc T, Wang-Gohrke Shan, Kropp Silke, Chang-Claude Jenny, , , Webb Penelope M, Chen Xiaoqing, Beesley Jonathan, Chenevix-Trench Georgia, Goode Ellen L, |
| Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. American journal of epidemiology 2009 Nov 170 (10): 1241-9. Reding Kerryn W, Li Christopher I, Weiss Noel S, Chen Chu, Carlson Christopher S, Duggan David, Thummel Kenneth E, Daling Janet R, Malone Kathleen |
| Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis. Genetics and molecular research : GMR 2015 14 (3): 9004-12. Zhang D, Li Q, Qu H-C, Yu T, Liu Y |
| Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms. Artificial cells, nanomedicine, and biotechnology 2019 Dec 47 (1): 1101-1112. Wang Le, Wang Hao, Wang Ting, Liu Jinhui, Chen Wei, Wang Yamin, Chen Chao, Zhu Hongli, Dai Pengg |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: